Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Inozyme Pharma, Inc. (INZY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
SC 13D/A
| Longitude Capital Partners III, LLC reports a 9.9% stake in INOZYME PHARMA, INC. |
| 08/07/2023 |
SC 13D/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 9.5% stake in Inozyme Pharma, Inc. |
| 05/23/2023 |
SC 13D/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 8.3% stake in Inozyme Pharma, Inc. |
| 04/04/2023 |
SC 13D/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 7.4% stake in Inozyme Pharma, Inc. |
| 04/28/2022 |
SC 13D/A
| Longitude Capital Partners III, LLC reports a 10.4% stake in INOZYME PHARMA, INC. |
| 07/30/2021 |
SC 13D/A
| Novo Holdings A/S reports a 5% stake in Inozyme Pharma, Inc. |
| 03/30/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/01/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/05/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
|
|